Boubaker K, Harzallah A, Ounissi M, Becha M, Guergueh T, Hedri H, Kaaroud H, Abderrahim E, Ben Abdellah T, Kheder A
Internal Medicine Department, Charles Nicolle Hospital, Tunis, Tunisia.
Transplant Proc. 2011 Jun;43(5):1742-6. doi: 10.1016/j.transproceed.2011.01.178.
There is a wide interest in epidemiologic studies assessing different causes of post-kidney transplantation rehospitalization. However, there is a paucity of knowledge on the long-term survival and graft function of rehospitalized kidney transplant recipients during the first year. Knowledge of posttransplant rehospitalization causes may help guide the preventive program at the first year. In our study, we assess causes for hospitalization and investigate the long-term patient and graft survival after non-fatal rehospitalization in kidney recipients during the first year.
We retrospectively studied the medical histories of 419 kidney transplant recipients whose operations were performed between 1986 and 2009 at Charles Nicolle Hospital, in Tunis, Tunisia. Among these patients, a total of 296 posttransplant rehospitalizations of kidney transplant recipients during the first year occurring in 191 (45.5%) patients were assessed. Clinical characteristics of the patients, including gender, age, reason for kidney failure, weight, height, blood group, length of pretransplant dialysis, immunosuppressive regimen, postoperative complications, the length of hospital stay, transplantation-admission interval, causes of rehospitalizations, graft loss, and mortality rate were reviewed. For donors, these demographics included age, gender, blood group, type of donor (deceased or living), and relationship to the recipient. Because rehospitalizations are possible for more than one cause, the sum of frequencies of rehospitalization causes is more than 100%.
There was 1 rehospitalization in 121 patients, 2 rehospitalizations in 47 patients, 3 rehospitalizations in 15 patients, 4 rehospitalizations in 5 patients, 5 rehospitalizations in 2 patients and 6 rehospitalizations in 1 patient. Rehospitalization was more frequent for diabetic patients without significant association. The causes of rehospitalization were infection in 221 cases (55.5%), renal dysfunction in 106 cases (26%), cardiovascular event in 10 cases (2.4%), and diabetic ketoacidosis in 11 cases (2.7%). The length of hospital stay was 22.5 ± 29.6 days, 20.15 ± 22.16 days, 25 ± 30 days and 23.4 ± 27.5 days, respectively, in the first, second, third, and fifth rehospitalizations. Median hospital stay for all rehospitalizations was between 14 and 16 days. The risk factors of rehospitalization were: use of mycophenolate mofetile (P = .0072), use of cyclosporine (P = .0073), and cytomegalovirus infection (P < .001). There was no significant correlation between rehospitalization and either lost of graft and death.
During the first year after kidney transplantation, rehospitalization was especially required because of infections and renal dysfunction. The risk factors of rehospitalization were cadaveric graft, use of mycophenolate mofetil, use of cyclosporine, and cytomegalovirus infection. To prevent and minimize rehospitalizations during the first year, a specific preventive program based on infection prevention and graft function monitoring should be established.
流行病学研究对评估肾移植后再入院的不同原因有着广泛兴趣。然而,对于再入院的肾移植受者在第一年的长期生存和移植肾功能情况,了解尚少。了解移植后再入院原因可能有助于指导第一年的预防方案。在我们的研究中,我们评估了住院原因,并调查了肾移植受者在第一年非致命性再入院后的长期患者生存和移植肾存活情况。
我们回顾性研究了1986年至2009年在突尼斯突尼斯市查尔斯·尼科勒医院接受手术的419例肾移植受者的病史。在这些患者中,共评估了191例(45.5%)患者在第一年发生的296次肾移植受者移植后再入院情况。回顾了患者的临床特征,包括性别、年龄、肾衰竭原因、体重、身高、血型、移植前透析时间、免疫抑制方案、术后并发症、住院时间、移植至入院间隔、再入院原因、移植肾丢失和死亡率。对于供者,这些人口统计学特征包括年龄、性别、血型、供者类型(已故或活体)以及与受者的关系。由于再入院可能有多种原因,再入院原因的频率总和超过100%。
121例患者有1次再入院,47例患者有2次再入院,15例患者有3次再入院,5例患者有4次再入院,2例患者有5次再入院,1例患者有6次再入院。糖尿病患者再入院更为频繁,但无显著相关性。再入院原因中,感染221例(55.5%),肾功能不全106例(26%),心血管事件10例(2.4%),糖尿病酮症酸中毒11例(2.7%)。首次、第二次、第三次和第五次再入院的住院时间分别为22.5±29.6天、20.15±22.16天、25±30天和23.4±27.5天。所有再入院的中位住院时间在14至16天之间。再入院的危险因素为:使用霉酚酸酯(P = 0.0072)、使用环孢素(P = 0.0073)和巨细胞病毒感染(P < 0.001)。再入院与移植肾丢失和死亡均无显著相关性。
肾移植后的第一年,因感染和肾功能不全尤其需要再次住院。再入院的危险因素为尸体供肾移植、使用霉酚酸酯、使用环孢素和巨细胞病毒感染。为预防和减少第一年的再入院情况,应建立基于感染预防和移植肾功能监测的特定预防方案。